Mammalian initiator apoptotic caspases

Caspases are a conserved family of cysteine proteases. They play diverse roles in inflammatory responses and apoptotic pathways. Among the caspases is a subgroup whose primary function is to initiate apoptosis. Within their long prodomains, caspases‐2, ‐9 and ‐12 contain a caspase activation and recruitment domain while caspases‐8 and ‐10 bear death effector domains. Activation follows the recruitment of the procaspase molecule via the prodomain to a high molecular mass complex. Despite sharing some common features, other aspects of the biochemistry, substrate specificity, regulation and signaling mechanisms differ between initiator apoptotic caspases. Defects in expression or activity of these caspases are related to certain pathological conditions including neurodegenerative disorders, autoimmune diseases and cancer.

[1]  W. Park,et al.  Caspase-8 gene is frequently inactivated by the frameshift somatic mutation 1225_1226delTG in hepatocellular carcinomas , 2005, Oncogene.

[2]  G. Núñez,et al.  Genes with homology to mammalian apoptosis regulators identified in zebrafish , 2000, Cell Death and Differentiation.

[3]  S. Jentsch,et al.  Dual role of BRUCE as an antiapoptotic IAP and a chimeric E2/E3 ubiquitin ligase. , 2004, Molecular cell.

[4]  A. Eggert,et al.  Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression , 2000, Oncogene.

[5]  Yigong Shi Caspase Activation Revisiting the Induced Proximity Model , 2004, Cell.

[6]  S. Srinivasula,et al.  FLAME-1, a Novel FADD-like Anti-apoptotic Molecule That Regulates Fas/TNFR1-induced Apoptosis* , 1997, The Journal of Biological Chemistry.

[7]  J. Zeuthen,et al.  The V410I (G1228A) variant of the caspase-10 gene is a common polymorphism of the Danish population. , 2000, Blood.

[8]  J. Blenis,et al.  Caspase-8 Is Required for Cell Death Induced by Expanded Polyglutamine Repeats , 1999, Neuron.

[9]  M. Manns,et al.  The Human Caspase-8 Promoter Sustains Basal Activity through SP1 and ETS-like Transcription Factors and Can Be Up-regulated by a p53-dependent Mechanism* , 2003, Journal of Biological Chemistry.

[10]  S. Ferrini,et al.  Expression and methylation of CASP8 in neuroblastoma: Identification of a promoter region , 2002, Nature Medicine.

[11]  J. Mankovich,et al.  Substrate Specificities of Caspase Family Proteases* , 1997, The Journal of Biological Chemistry.

[12]  Denis Bouchard,et al.  Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. , 2003, Genes & development.

[13]  J Yuan,et al.  Caspases: an ancient cellular sword of Damocles , 2004, Cell Death and Differentiation.

[14]  Alexei Degterev,et al.  A decade of caspases , 2003, Oncogene.

[15]  T. Kang,et al.  Caspase-8 Serves Both Apoptotic and Nonapoptotic Roles1 , 2004, The Journal of Immunology.

[16]  J. Tschopp,et al.  The PIDDosome, a Protein Complex Implicated in Activation of Caspase-2 in Response to Genotoxic Stress , 2004, Science.

[17]  D. Goeddel,et al.  FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. , 1998, Science.

[18]  J. Beckmann,et al.  Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. , 1998, Immunity.

[19]  F. Beguinot,et al.  Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Death-inducing Signaling Complex and Its Modulation by c-FLIP and PED/PEA-15 in Glioma Cells* , 2002, The Journal of Biological Chemistry.

[20]  M. Peter,et al.  Identification of the Cytolinker Plectin as a Major Early In Vivo Substrate for Caspase 8 during CD95- and Tumor Necrosis Factor Receptor-Mediated Apoptosis , 2000, Molecular and Cellular Biology.

[21]  John Calvin Reed,et al.  The c‐IAP‐1 and c‐IAP‐2 proteins are direct inhibitors of specific caspases , 1997, The EMBO journal.

[22]  M. Hayden,et al.  Cell death attenuation by `Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex , 1998, Cell Death and Differentiation.

[23]  S. Fulda,et al.  Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer , 2001, Oncogene.

[24]  G M Kasof,et al.  Livin, a Novel Inhibitor of Apoptosis Protein Family Member* , 2001, The Journal of Biological Chemistry.

[25]  S. Toyooka,et al.  Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines. , 2002, Cancer research.

[26]  M. Beal,et al.  Caspase-9 Activation Results in Downstream Caspase-8 Activation and Bid Cleavage in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinson's Disease , 2001, The Journal of Neuroscience.

[27]  J. Blenis,et al.  FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. , 2000, Immunity.

[28]  N. Thornberry,et al.  Caspase-2 Is Localized at the Golgi Complex and Cleaves Golgin-160 during Apoptosis , 2000, The Journal of cell biology.

[29]  P. Vandenabeele,et al.  A Novel Caspase-2 Complex Containing TRAF2 and RIP1* , 2005, Journal of Biological Chemistry.

[30]  L. Ellis,et al.  Increased Apoptosis in Metastatic Human Colonic Adenocarcinomas , 2002, Cancer biology & therapy.

[31]  G. Salvesen,et al.  Activation of caspases-8 and -10 by FLIP(L). , 2004, The Biochemical journal.

[32]  J. Tschopp,et al.  Induction of TNF Receptor I-Mediated Apoptosis via Two Sequential Signaling Complexes , 2003, Cell.

[33]  D. Vaux,et al.  Caspase-2 is not required for thymocyte or neuronal apoptosis even though cleavage of caspase-2 is dependent on both Apaf-1 and caspase-9 , 2002, Cell Death and Differentiation.

[34]  D. Yew,et al.  Fas and activated caspase 8 in normal, Alzheimer and multiple infarct brains , 2004, Neuroscience Letters.

[35]  J. Bertin,et al.  Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Xiaodong Wang,et al.  Smac, a Mitochondrial Protein that Promotes Cytochrome c–Dependent Caspase Activation by Eliminating IAP Inhibition , 2000, Cell.

[37]  J C Reed,et al.  Caspase-9 Can Be Activated without Proteolytic Processing* , 1999, The Journal of Biological Chemistry.

[38]  Jun Wang,et al.  Molecular cloning and characterization of murine caspase-12 gene promoter. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[39]  L. Rorke,et al.  Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[40]  T. Mak,et al.  Apaf1 Is Required for Mitochondrial Pathways of Apoptosis and Brain Development , 1998, Cell.

[41]  J. Tschopp,et al.  TRAIL receptor-2 signals apoptosis through FADD and caspase-8 , 2000, Nature Cell Biology.

[42]  Gerhard Wagner,et al.  Solution Structure of the RAIDD CARD and Model for CARD/CARD Interaction in Caspase-2 and Caspase-9 Recruitment , 1998, Cell.

[43]  F. Behm,et al.  Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN , 2000, Nature Medicine.

[44]  C. Cotman,et al.  Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[45]  L. Corcos,et al.  The human caspase-2 gene: alternative promoters, pre-mRNA splicing and AUG usage direct isoform-specific expression , 2003, Oncogene.

[46]  N. Thornberry,et al.  A Combinatorial Approach Defines Specificities of Members of the Caspase Family and Granzyme B , 1997, The Journal of Biological Chemistry.

[47]  Y. Yaoita,et al.  Structure, Expression, and Function of the Xenopus laevis Caspase Family* , 2000, The Journal of Biological Chemistry.

[48]  S. Srinivasula,et al.  Engineering a Dimeric Caspase-9: A Re-evaluation of the Induced Proximity Model for Caspase Activation , 2005, PLoS biology.

[49]  D. Baltimore,et al.  Autoproteolytic activation of pro-caspases by oligomerization. , 1998, Molecular cell.

[50]  Keisuke Kuida,et al.  Reduced Apoptosis and Cytochrome c–Mediated Caspase Activation in Mice Lacking Caspase 9 , 1998, Cell.

[51]  S. Srinivasula,et al.  Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.

[52]  Fengzhi Li,et al.  Control of apoptosis and mitotic spindle checkpoint by survivin , 1998, Nature.

[53]  H. Nakayama,et al.  A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. , 2001, Molecular cell.

[54]  W. Park,et al.  CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas. , 2005, Cancer research.

[55]  William H. Nesse,et al.  Activation of Caspase-8 in the Alzheimer's Disease Brain , 2001, Neurobiology of Disease.

[56]  C. Weber,et al.  The death domain superfamily: a tale of two interfaces? , 2001, Trends in biochemical sciences.

[57]  Hua Liu,et al.  Endoplasmic reticulum stress-associated caspase 12 mediates cisplatin-induced LLC-PK1 cell apoptosis. , 2005, Journal of the American Society of Nephrology : JASN.

[58]  J C Reed,et al.  IAP family proteins--suppressors of apoptosis. , 1999, Genes & development.

[59]  David L. Vaux,et al.  Bcl-2–regulated apoptosis and cytochrome c release can occur independently of both caspase-2 and caspase-9 , 2004, The Journal of cell biology.

[60]  C. Cotman,et al.  Caspase-9 Activation and Caspase Cleavage of tau in the Alzheimer's Disease Brain , 2002, Neurobiology of Disease.

[61]  Stephen W. Fesik,et al.  NMR Structure and Mutagenesis of the Third Bir Domain of the Inhibitor of Apoptosis Protein XIAP* , 2000, The Journal of Biological Chemistry.

[62]  D. Kabelitz,et al.  Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. , 2004, Immunity.

[63]  R. Gentz,et al.  I-FLICE, a Novel Inhibitor of Tumor Necrosis Factor Receptor-1- and CD-95-induced Apoptosis* , 1997, The Journal of Biological Chemistry.

[64]  Suzanne Cory,et al.  The Bcl-2 family: roles in cell survival and oncogenesis , 2003, Oncogene.

[65]  C. Caltagirone,et al.  Increased caspase activation in peripheral blood mononuclear cells of patients with Alzheimer's disease , 2004, Experimental Neurology.

[66]  C. Briand,et al.  Insights into the regulatory mechanism for caspase-8 activation. , 2003, Molecular cell.

[67]  A. Johnson,et al.  Characterization of the chicken interleukin-1beta converting enzyme (caspase-1) cDNA and expression of caspase-1 mRNA in the hen. , 1998, Gene.

[68]  P. Ekert,et al.  Caspase‐2 is resistant to inhibition by inhibitor of apoptosis proteins (IAPs) and can activate caspase‐7 , 2005, The FEBS journal.

[69]  P. Leder,et al.  RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death , 1995, Cell.

[70]  J. Puck,et al.  Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency , 2002, Nature.

[71]  E. Jaffe,et al.  Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. , 1997, Blood.

[72]  A. Johnson,et al.  Caspase-3 and -6 Expression and Enzyme Activity in Hen Granulosa Cells1 , 2000, Biology of reproduction.

[73]  Yigong Shi,et al.  Oligomerization and activation of caspase-9, induced by Apaf-1 CARD , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[74]  A. Porter,et al.  Molecular Cloning and Characterization of Two Novel Pro-apoptotic Isoforms of Caspase-10* , 1999, The Journal of Biological Chemistry.

[75]  D. Altieri Molecular circuits of apoptosis regulation and cell division control: The survivin paradigm , 2004, Journal of cellular biochemistry.

[76]  Y. Lazebnik,et al.  Identification of an endogenous dominant-negative short isoform of caspase-9 that can regulate apoptosis. , 1999, Cancer research.

[77]  Vishva M. Dixit,et al.  RAIDD is a new 'death' adaptor molecule , 1997, Nature.

[78]  Stephen W. Fesik,et al.  NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP , 1999, Nature.

[79]  J C Reed,et al.  IAPs block apoptotic events induced by caspase‐8 and cytochrome c by direct inhibition of distinct caspases , 1998, The EMBO journal.

[80]  P. Vandenabeele,et al.  Caspase-12: an overview , 2004, Cell Death and Differentiation.

[81]  P. Branton,et al.  p28 Bap31, a Bcl-2/Bcl-XL- and Procaspase-8–associated Protein in the Endoplasmic Reticulum , 1997, The Journal of cell biology.

[82]  A. Thorburn,et al.  Direct Binding of Fas-associated Death Domain (FADD) to the Tumor Necrosis Factor-related Apoptosis-inducing Ligand Receptor DR5 Is Regulated by the Death Effector Domain of FADD* , 2004, Journal of Biological Chemistry.

[83]  M. Peter,et al.  Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor. , 1995, The EMBO journal.

[84]  L. Wang,et al.  Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death , 1994, Cell.

[85]  J. Tschopp,et al.  The Long Form of FLIP Is an Activator of Caspase-8 at the Fas Death-inducing Signaling Complex* , 2002, The Journal of Biological Chemistry.

[86]  S. Shaham Identification of Multiple Caenorhabditis elegansCaspases and Their Potential Roles in Proteolytic Cascades* , 1998, The Journal of Biological Chemistry.

[87]  Brent R. Stockwell,et al.  An Induced Proximity Model for Caspase-8 Activation* , 1998, The Journal of Biological Chemistry.

[88]  J. Puck,et al.  Inherited Human Caspase 10 Mutations Underlie Defective Lymphocyte and Dendritic Cell Apoptosis in Autoimmune Lymphoproliferative Syndrome Type II , 1999, Cell.

[89]  N. Thornberry,et al.  Determination of caspase specificities using a peptide combinatorial library. , 2000, Methods in enzymology.

[90]  N. Kabra,et al.  Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1 , 1998, Nature.

[91]  John D Minna,et al.  Differential Inactivation of Caspase-8 in Lung Cancers , 2002, Cancer biology & therapy.

[92]  J. Blenis,et al.  Death Receptor Recruitment of Endogenous Caspase-10 and Apoptosis Initiation in the Absence of Caspase-8* , 2001, The Journal of Biological Chemistry.

[93]  E. Koonin,et al.  Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. , 2000, Molecular cell.

[94]  A. Kaye,et al.  Caspase 8 is absent or low in many ex vivo gliomas , 2005, Cancer.

[95]  J. Tschopp,et al.  Cellular FLIP Long Form Augments Caspase Activity and Death of T Cells through Heterodimerization with and Activation of Caspase-81 , 2005, The Journal of Immunology.

[96]  A. Hackam,et al.  Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease , 2004, Cell Death and Differentiation.

[97]  J. Camonis,et al.  A Novel Protein That Interacts with the Death Domain of Fas/APO1 Contains a Sequence Motif Related to the Death Domain (*) , 1995, The Journal of Biological Chemistry.

[98]  Arul M. Chinnaiyan,et al.  FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis , 1995, Cell.

[99]  J. Redondo,et al.  The Up-regulation of Human Caspase-8 by Interferon-γ in Breast Tumor Cells Requires the Induction and Action of the Transcription Factor Interferon Regulatory Factor-1* , 2004, Journal of Biological Chemistry.

[100]  H. Chun,et al.  Caspase-10 is an initiator caspase in death receptor signaling , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[101]  Francesco Cecconi,et al.  Apaf1 (CED-4 Homolog) Regulates Programmed Cell Death in Mammalian Development , 1998, Cell.

[102]  S. Korsmeyer,et al.  Caspase Cleaved BID Targets Mitochondria and Is Required for Cytochrome c Release, while BCL-XL Prevents This Release but Not Tumor Necrosis Factor-R1/Fas Death* , 1999, The Journal of Biological Chemistry.

[103]  A. Eggert,et al.  Loss of caspase-8 mRNA expression is common in childhood primitive neuroectodermal brain tumour/medulloblastoma. , 2002, European journal of cancer.

[104]  Junying Yuan,et al.  Human ICE/CED-3 Protease Nomenclature , 1996, Cell.

[105]  T. Hunter,et al.  The inhibitor of apoptosis, cIAP2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7. , 2000, The Journal of biological chemistry.

[106]  M. Nguyen,et al.  The procaspase-8 isoform, procaspase-8L, recruited to the BAP31 complex at the endoplasmic reticulum , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[107]  Y. Okamura-Oho,et al.  Extended polyglutamine selectively interacts with caspase-8 and -10 in nuclear aggregates , 2001, Cell Death and Differentiation.

[108]  F. Martinon,et al.  Activation of a pro‐apoptotic amplification loop through inhibition of NF‐κB‐dependent survival signals by caspase‐mediated inactivation of RIP , 2000, FEBS letters.

[109]  S. Srinivasula,et al.  Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[110]  V. Dixit,et al.  ERICE, a Novel FLICE-activatable Caspase* , 1998, The Journal of Biological Chemistry.

[111]  V. Dixit,et al.  A Novel Family of Viral Death Effector Domain-containing Molecules That Inhibit Both CD-95- and Tumor Necrosis Factor Receptor-1-induced Apoptosis* , 1997, The Journal of Biological Chemistry.

[112]  Xiaolu Yang,et al.  c‐FLIPL is a dual function regulator for caspase‐8 activation and CD95‐mediated apoptosis , 2002, The EMBO journal.

[113]  D. Goeddel,et al.  The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation , 1995, Cell.

[114]  T. Noda,et al.  Apollon ubiquitinates SMAC and caspase-9, and has an essential cytoprotection function , 2004, Nature Cell Biology.

[115]  Junying Yuan,et al.  Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β , 2000, Nature.

[116]  S. Srinivasula,et al.  In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[117]  Kenshi Hayashi,et al.  Characterization of caspase-8L: a novel isoform of caspase-8 that behaves as an inhibitor of the caspase cascade. , 2002, Blood.

[118]  K. Lauber,et al.  A caspase-related protease regulates apoptosis in yeast. , 2002, Molecular cell.

[119]  J. Minna,et al.  Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification , 2002, Oncogene.

[120]  Y. Lazebnik,et al.  Caspase-9 and APAF-1 form an active holoenzyme. , 1999, Genes & development.

[121]  S. Srinivasula,et al.  CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP. , 1997, Cancer research.

[122]  Y. Lazebnik,et al.  Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation , 2000, Nature Medicine.

[123]  Y. Goltsev,et al.  CASH, a Novel Caspase Homologue with Death Effector Domains* , 1997, The Journal of Biological Chemistry.

[124]  David Wallach,et al.  Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell Death , 1996, Cell.

[125]  M. Grütter,et al.  Caspase-8 specificity probed at subsite S(4): crystal structure of the caspase-8-Z-DEVD-cho complex. , 2000, Journal of molecular biology.

[126]  R. Moritz,et al.  HtrA2 Promotes Cell Death through Its Serine Protease Activity and Its Ability to Antagonize Inhibitor of Apoptosis Proteins* , 2002, The Journal of Biological Chemistry.

[127]  S. Ferrini,et al.  Expression of the caspase-8 gene in neuroblastoma cells is regulated through an essential interferon-sensitive response element (ISRE) , 2004, Cell Death and Differentiation.

[128]  K. Nakanishi,et al.  An Endoplasmic Reticulum Stress-specific Caspase Cascade in Apoptosis , 2002, The Journal of Biological Chemistry.

[129]  L. Greene,et al.  Death in the Balance: Alternative Participation of the Caspase-2 and -9 Pathways in Neuronal Death Induced by Nerve Growth Factor Deprivation , 2001, The Journal of Neuroscience.

[130]  D. Vaux,et al.  Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs , 2001, Genome Biology.

[131]  V. Dixit,et al.  Fas-associated Death Domain Protein Interleukin-1β-converting Enzyme 2 (FLICE2), an ICE/Ced-3 Homologue, Is Proximally Involved in CD95- and p55-mediated Death Signaling* , 1997, The Journal of Biological Chemistry.

[132]  C. Weber,et al.  A docking model of key components of the DISC complex: death domain superfamily interactions redefined , 2001, FEBS letters.

[133]  M. Moskowitz,et al.  Defects in regulation of apoptosis in caspase-2-deficient mice. , 1998, Genes & development.

[134]  S. Lowe,et al.  Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. , 1998, Genes & development.

[135]  P. Bucher,et al.  The CARD domain: a new apoptotic signalling motif. , 1997, Trends in biochemical sciences.

[136]  A. Grosse-Wilde,et al.  Caspase‐10 is recruited to and activated at the native TRAIL and CD95 death‐inducing signalling complexes in a FADD‐dependent manner but can not functionally substitute caspase‐8 , 2002, The EMBO journal.

[137]  Robert L Moritz,et al.  Identification of DIABLO, a Mammalian Protein that Promotes Apoptosis by Binding to and Antagonizing IAP Proteins , 2000, Cell.

[138]  K. Nakanishi,et al.  Identification of a Caspase-9 Substrate and Detection of Its Cleavage in Programmed Cell Death during Mouse Development* , 2001, The Journal of Biological Chemistry.

[139]  S. Rabacchi,et al.  Caspase-2 Mediates Neuronal Cell Death Induced by β-Amyloid , 2000, The Journal of Neuroscience.

[140]  R. Honda,et al.  X-linked inhibitor of apoptosis functions as ubiquitin ligase toward mature caspase-9 and cytosolic Smac/DIABLO. , 2005, Journal of biochemistry.

[141]  L. Eckhart,et al.  Human caspase 12 has acquired deleterious mutations. , 2002, Biochemical and biophysical research communications.

[142]  C. March,et al.  Molecular cloning of the interleukin-1 beta converting enzyme. , 1992, Science.

[143]  R. Ho,et al.  Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression. , 2001, Cancer research.

[144]  Björn Rotter,et al.  AlphaII-spectrin is an in vitro target for caspase-2, and its cleavage is regulated by calmodulin binding. , 2004, The Biochemical journal.

[145]  J. Tschopp,et al.  Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors , 1997, Nature.

[146]  U. Kikkawa,et al.  Akt phosphorylation site found in human caspase-9 is absent in mouse caspase-9. , 1999, Biochemical and biophysical research communications.

[147]  K. Kuida,et al.  Caspase-9 processing by caspase-3 via a feedback amplification loop in vivo , 2001, Cell Death and Differentiation.

[148]  B. Trask,et al.  MRIT, a novel death-effector domain-containing protein, interacts with caspases and BclXL and initiates cell death. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[149]  Junying Yuan,et al.  Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis , 1998, Cell.

[150]  K. Bhalla,et al.  The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis. , 2000, Cancer research.

[151]  K. Jin,et al.  Two caspase‐2 transcripts are expressed in rat hippocampus after global cerebral ischemia , 2002, Journal of neurochemistry.

[152]  Y. Hayashi,et al.  Allelic imbalance on chromosome 2q and alterations of the caspase 8 gene in neuroblastoma , 2001, Oncogene.

[153]  M. Peter,et al.  FLICE Is Predominantly Expressed as Two Functionally Active Isoforms, Caspase-8/a and Caspase-8/b* , 1997, The Journal of Biological Chemistry.

[154]  J C Reed,et al.  Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases , 1999, The EMBO journal.

[155]  Xuejun Jiang,et al.  Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. , 2002, Molecular cell.

[156]  E. Hirsch,et al.  Caspase-8 Is an Effector in Apoptotic Death of Dopaminergic Neurons in Parkinson's Disease, But Pathway Inhibition Results in Neuronal Necrosis , 2001, The Journal of Neuroscience.

[157]  S. Fulda,et al.  IFNγ sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway , 2002, Oncogene.

[158]  Stefan Grimm,et al.  The Death Domain Kinase RIP Mediates the TNF-Induced NF-κB Signal , 1998 .

[159]  A. Anel,et al.  Doxorubicin treatment activates a Z-VAD-sensitive caspase, which causes deltapsim loss, caspase-9 activity, and apoptosis in Jurkat cells. , 2000, Experimental cell research.

[160]  D. Vaux,et al.  A novel Apaf-1–independent putative caspase-2 activation complex , 2002, The Journal of cell biology.

[161]  D. Seol,et al.  A Caspase-9 Variant Missing the Catalytic Site Is an Endogenous Inhibitor of Apoptosis* , 1999, The Journal of Biological Chemistry.

[162]  Margot Thome,et al.  Inhibition of death receptor signals by cellular FLIP , 1997, Nature.

[163]  G. Salvesen,et al.  Apoptosis: IAP proteins: blocking the road to death's door , 2002, Nature Reviews Molecular Cell Biology.

[164]  D. Goeddel,et al.  TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. , 1996, Immunity.

[165]  J. Mcwhir,et al.  In situ analysis of Raidd-beta-galactosidase fusion gene expression in transgenic mouse midgestation embryos , 2005, Transgenic Research.

[166]  E. Solary,et al.  Identification of a caspase-2 isoform that behaves as an endogenous inhibitor of the caspase cascade. , 2000, Cancer research.

[167]  Christophe Briand,et al.  Crystal Structure of Caspase-2, Apical Initiator of the Intrinsic Apoptotic Pathway* , 2003, Journal of Biological Chemistry.

[168]  D. Goeddel,et al.  Casper is a FADD- and caspase-related inducer of apoptosis. , 1997, Immunity.

[169]  David L. Vaux,et al.  IAPs, RINGs and ubiquitylation , 2005, Nature Reviews Molecular Cell Biology.

[170]  D. Vaux,et al.  Diablo Promotes Apoptosis by Removing Miha/Xiap from Processed Caspase 9 , 2001, The Journal of cell biology.

[171]  M. Venkatachalam,et al.  cDNA cloning and promoter analysis of rat caspase-9. , 2001, The Biochemical journal.

[172]  José Luis de la Pompa,et al.  Differential Requirement for Caspase 9 in Apoptotic Pathways In Vivo , 1998, Cell.

[173]  G. Salvesen,et al.  The protein structures that shape caspase activity, specificity, activation and inhibition. , 2004, The Biochemical journal.

[174]  A. Johnson,et al.  Characterization of the avian Ich-1 cDNA and expression of Ich-1L mRNA in the hen ovary. , 1997, Gene.

[175]  G. Cohen,et al.  Fas-associated Death Domain Protein and Caspase-8 Are Not Recruited to the Tumor Necrosis Factor Receptor 1 Signaling Complex during Tumor Necrosis Factor-induced Apoptosis* , 2003, Journal of Biological Chemistry.

[176]  W. Park,et al.  Inactivating mutations of caspase-8 gene in colorectal carcinomas. , 2003, Gastroenterology.

[177]  Hong-Bing Shu,et al.  TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways , 1996, Cell.

[178]  S. Chen,et al.  CLARP, a death effector domain-containing protein interacts with caspase-8 and regulates apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[179]  John E. Eriksson,et al.  Rapid Turnover of c-FLIPshort Is Determined by Its Unique C-terminal Tail* , 2005, Journal of Biological Chemistry.

[180]  L. Eckhart,et al.  Evidence that caspase-13 is not a human but a bovine gene. , 2001, Biochemical and biophysical research communications.

[181]  R. Liddington,et al.  Dimer formation drives the activation of the cell death protease caspase 9 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[182]  F. Brasseur,et al.  A CASP-8 Mutation Recognized by Cytolytic T Lymphocytes on a Human Head and Neck Carcinoma , 1997, The Journal of experimental medicine.

[183]  S. Srinivasula,et al.  Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms , 2004, Nature.

[184]  R. Flavell,et al.  Strain‐Dependent Neurodevelopmental Abnormalities in Caspase‐3‐Deficient Mice , 2002, Journal of neuropathology and experimental neurology.

[185]  Shai Shaham,et al.  The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme , 1993, Cell.

[186]  Yigong Shi,et al.  Structure of the apoptotic protease-activating factor 1 bound to ADP , 2005, Nature.